فهرست:
ندارد.
منبع:
1. Nazemi Tabrizi M.J. EN, Sedaghat Y.,Mostafa S. . Efficacy Of Oral Etonian In Patients With Generalized Cutaneous Lichen Planes. Iranian Journal Of Dermatology 2006;9(1(35)):46-9.
2. W. Burket L. SGM, Glick M.,A. Ship J. . Burket's oral medicine diagnosis and treatment. eleventh ed. Hamilton: BC Decker2008. p. 89-95,260.
3. Beigom Taheri J, Anbari F, Maleki Z, Boostani S, Zarghi A, Pouralibaba F. Efficacy of Elaeagnus angustifolia Topical Gel in the Treatment of Symptomatic Oral Lichen Planus. J Dent Res Dent Clin Dent Prospects. 2010 Winter;4(1):29-32.
4. Frieling U, Bonsmann G, Schwarz T, Luger TA, Beissert S. Treatment of severe lichen planus with mycophenolate mofetil. J Am Acad Dermatol. 2003 Dec;49(6):1063-6.
5. Iaccarino L, Rampudda M, Canova M, Della Libera S, Sarzi-Puttinic P, Doria A. Mycophenolate mofetil: what is its place in the treatment of autoimmunerheumatic diseases? Autoimmun Rev. 2007 Jan;6(3):190-5.
6. Mutasim DF. Management of autoimmune bullous diseases: pharmacology and therapeutics. J Am Acad Dermatol. 2004 Dec;51(6):859-77; quiz 78-80.
7. Nousari HC, Sragovich A, Kimyai-Asadi A, Orlinsky D, Anhalt GJ. Mycophenolate mofetil in autoimmune and inflammatory skin disorders. J Am Acad Dermatol. 1999 Feb;40(2 Pt 1):265-8.
8. Knapp S, Bertelmann E, Hartmann C, Keipert S, Pleyer U. Intraocular availability of topically applied mycophenolate mofetil in rabbits. J Ocul Pharmacol Ther. 2003 Apr;19(2):181-92.
9. Cho BK, Sah D, Chwalek J, Roseborough I, Ochoa B, Chiang C, et al. Efficacy and safety of mycophenolate mofetil for lichen planopilaris. J Am Acad Dermatol. 2010 Mar;62(3):393-7.
10. Dalmau J, Puig L, Roe E, Peramiquel L, Campos M, Alomar A. Successful treatment of oral erosive lichen planus with mycophenolate mofetil. J Eur Acad Dermatol Venereol. 2007 Feb;21(2):259-60.
11. Orvis AK, Wesson SK, Breza TS, Jr., Church AA, MitchellCL, Watkins SW. Mycophenolate mofetil in dermatology. J Am Acad Dermatol. 2009 Feb;60(2):183-99; quiz 200-2.
12. Shaikh R, Raj Singh TR, Garland MJ, Woolfson AD, Donnelly RF. Mucoadhesive drug delivery systems. J Pharm Bioallied Sci. 2011 Jan;3(1):89-100.
13. Fulton B, Markham A. Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation. Drugs. 1996 Feb;51(2):278-98.
14. Andrews GP, Laverty TP, Jones DS. Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm. 2009 Mar;71(3):505-18.
15. Regezi JA SJ, Jordan RCK. Oral Pathology: Clinical Pathologic Correlations. 5th ed. St. Louis: Saunders; 2008.
16. Neville BW DD, Allen CM, Bouquot JE. Oral and Maxillofacial Pathology. 3rd ed. 1st edn. Philadelphia: WB Saunders Company,; 2009.
17. Prime SS, Pring M, Davies M, Paterson IC. TGF-beta signal transduction in oro-facial health and non-malignant disease (part I). Crit Rev Oral Biol Med. 2004;15(6):324-36.
18. Wray D LG, Dagg JH, Felix DH, Scully C. Textbook of general and oral medicine. 1st ed. Edinburgh. Pagination: Churchill Livingstone; 1999.
19. Raghavendra Kini DN, Ankit Saha. Therapeutic Management of Oral Lichen Planus: A Review for the Clinicians. World Journal of Dentistry. 2011;2(3):249-53.
20. Won TH, Park SY, Kim BS, Seo PS, Park SD. Levamisole Monotherapy for Oral Lichen Planus. Ann Dermatol. 2009 8/;21(3):250-4.
21. Wohlrab J, Jahn K, Plaetzer M, Neubert R, Marsch WC. Topical application of mycophenolate mofetil in plaque-type psoriasis. Br J Dermatol. 2001 Jun;144(6):1263-4.
22. Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O'Nan P, et al. Sequential therapies for proliferative lupus nephritis. N Engl J Med. 2004 Mar 4;350(10):971-80.
23. Grundmann-Kollmann M, Podda M, Ochsendorf F, Boehncke WH, Kaufmann R, Zollner TM. Mycophenolate mofetil is effective in the treatment of atopic dermatitis. Arch Dermatol. 2001 Jul;137(7):870-3.
24. Neuber K, Schwartz I, Itschert G, Dieck AT. Treatment of atopic eczema with oral mycophenolate mofetil. Br J Dermatol. 2000 Aug;143(2):385-91.
25. Karim MY, Alba P, Cuadrado MJ, Abbs IC, D'Cruz DP, Khamashta MA, et al. Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. Rheumatology (Oxford). 2002 Aug;41(8):876-82.
26. Beissert S, Werfel T, Frieling U, Bohm M, Sticherling M, Stadler R, et al. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid. Arch Dermatol. 2007 Dec;143(12):1536-42.
27. Beissert S, Werfel T, Frieling U, Bohm M, Sticherling M, Stadler R, et al. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Arch Dermatol. 2006 Nov;142(11):1447-54.
28. Wee J, Shirlaw P, Challacombe S, Setterfield J. Efficacy of mycophenolate mofetil in severe mucocutaneous lichen planus: a retrospective review of 10 patients. British Journal of Dermatology. 2012;167(1):36-43.
29. Pisoni CN, Obermoser G, Cuadrado MJ, Sanchez FJ, Karim Y, Sepp NT, et al. Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetil. Clin Exp Rheumatol. 2005 May-Jun;23(3):393-6.
30. Park H. The emergence of mycophenolate mofetilin dermatology: from its roots in the world of organ transplantation to its versatile role in the dermatology treatment room. J Clin Aesthet Dermatol. 2011 Jan;4(1):18-27.
31. Kitchin JE, Pomeranz MK, Pak G, Washenik K, Shupack JL. Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses. J Am Acad Dermatol. 1997 Sep;37(3 Pt 1):445-9.
32. Kim HC, Park SB. Mycophenolate mofetil-induced ischemic colitis. Transplant Proc. 2000 Nov;32(7):1896-7.
33. Garrigue V, Canet S, Dereure O, Panabieres O, Augias D, Chong G, et al. Oral ulcerations in a renal transplant recipient: a mycophenolate mofetil-induced complication? Transplantation. 2001 Sep 15;72(5):968-9.
34. Apostolou T, Tsagalis G, Koutroubas G, Hadjiconstantinou V, Drakopoulos S. Mycophenolate mofetil and oral ulcerations. Transplantation. 2004 Jun 27;77(12):1911-2.
35. Sievers TM, Rossi SJ, Ghobrial RM, Arriola E, Nishimura P, Kawano M, et al. Mycophenolate mofetil. Pharmacotherapy. 1997 Nov-Dec;17(6):1178-97.
36. Repchinsky C, Welbanks L, Bisson R. Compendium of pharmaceuticalsand specialties: the Canadian drug reference for health professionals: Canada: Canadian Pharmacists Association, 2002; 2002.
37. Schanz S, Ulmer A, Rassner G, Fierlbeck G. Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil. Br J Dermatol. 2002 Jul;147(1):174-8.
38. Lee MR, Cooper AJ. Mycophenolate mofetil in pyoderma gangrenosum. J Dermatolog Treat. 2004 Sep;15(5):303-7.
39. PDR electronic library Mycophenolate mofetil (CellCept) productinformation [CD-ROM] [Internet]. Nutley, NJ: Roche laboratories;. 1995.